Karen I Guerin

Title: Karen I Guerin: Innovator in Gene Therapy

Introduction

Karen I Guerin is a notable inventor based in Braintree, MA (US). She has made significant contributions to the field of gene therapy, particularly through her work on adeno-associated virus (AAV) virions. Her innovative approach has the potential to enhance gene delivery methods, especially for retinal cells.

Latest Patents

Karen I Guerin holds a patent for "Adeno-associated virus virions with variant capsids and methods of use thereof." This patent describes recombinant AAV virions that include a variant capsid protein and a heterologous nucleic acid. The rAAV virions are designed for the effective delivery of gene products to retinal cells, providing methods for delivering these gene products to individuals.

Career Highlights

Throughout her career, Karen has worked with prominent organizations such as Novartis AG and the University of California. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include John G Flannery and Scott F Geller. Their collaborative efforts have further advanced the research and development of gene therapy techniques.

Conclusion

Karen I Guerin's work exemplifies the innovative spirit in the field of gene therapy. Her contributions through patents and collaborations continue to pave the way for advancements in medical science.